Algert Global’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-18,958
Closed -$205K 1146
2021
Q3
$205K Sell
18,958
-5,702
-23% -$51.9K 0.03% 914
2021
Q2
$225K Buy
+24,660
New +$228K 0.08% 333
2020
Q4
Sell
-21,000
Closed -$56K 515
2020
Q3
$56K Buy
+21,000
New +$77.9K 0.02% 374

Other funds holding GRTS

Algert Global's GRTS Position: Q4 2021 in Review

Algert Global sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2021, closing a stake of 18,958 shares — an estimated $205K sold.

Algert Global first reported a position in GRTS in Q3 2020 and held it in 3 quarters. The position peaked at $225K in Q2 2021. 115 funds tracked by Wall St. Rank hold GRTS as of Q4 2021.

  • Algert Global reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Algert Global sold 18,958 Gritstone bio, Inc. Common Stock shares in Q4 2021, an estimated $205K.
  • Algert Global first reported a position in Gritstone bio, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Algert Global's Gritstone bio, Inc. Common Stock position peaked at $225K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2021.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.